Aivo Biosciences
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Aivo Biosciences is a preclinical-stage biotechnology company founded in 2021 and based in Cambridge, Massachusetts. The company is focused on developing transformative small molecule therapeutics for central nervous system (CNS) disorders, with a core expertise in M1 muscarinic receptor agonism. Its lead program targets schizophrenia and psychosis, with plans to expand into other neuropsychiatric and neurodegenerative diseases.
Small Molecules